Literature DB >> 15930211

Is bloodstream infection preventable among premature infants? A tale of two cities.

Hany Aly1, Victor Herson, Anne Duncan, Jill Herr, Jean Bender, Kantilal Patel, Ayman A E El-Mohandes.   

Abstract

BACKGROUND: Bloodstream infection (BSI) is a significant cause of morbidity and death encountered in the NICU. The rates of BSIs vary significantly in NICUs across the nation. However, no attempt has been made to correlate this variation with specific infection-control practices and policies. We experienced a significant increase in BSIs in the NICU at the George Washington University Hospital and were seeking additional precautionary measures to reduce BSI rates. Our objective was to review policies and practices associated with lower infection rates nationally and to test their reproducibility in our unit. DESIGN AND METHODS: Data on BSI rates in 16 NICUs were reviewed. The BSI rate at Connecticut Children's Medical Center (CCMC) was the lowest among those reviewed. A team from George Washington University Hospital conducted a site visit to CCMC to examine their practices. Differences in the aseptic precautions used for intravenous line management were noted at CCMC, where a closed medication system is used. This system was applied at George Washington University Hospital starting January 1, 2001. Infection rates among low birth weight infants (<2500 g) at George Washington University Hospital in the period from January 1998 to December 2000 (group 1) were compared with those in the period from January 2001 to December 2003 (group 2). Comparisons between the 2 cohorts were made with Fisher's exact test, the Kruskal-Wallis test, and Student's t test. Multivariate analysis was used to control for differences in birth weight, gestational age, central line days, and ventilator days. Analyses were repeated for the subgroup of very low birth weight infants (<1500 g).
RESULTS: A total of 536 inborn low birth weight infants were included in this retrospective study (group 1, N = 169 infants; group 2, N = 367). The incidence of sepsis decreased significantly from group 1 to group 2 (25.4% and 2.2%, respectively). The reduction of sepsis observed in association with the new practice was statistically significant after controlling for birth weight, central line days, and ventilator days in a multiple regression model (regression coefficient: 0.95 +/- 0.29). The odds ratio of reduction in sepsis after implementation of the new practice was 2.6 (95% confidence interval: 1.5-4.5). The central line-related BSI rate decreased from 15.17 infections per 1000 line days to 2.1 infections per 1000 line days. The study included 233 very low birth weight infants, ie, 90 in group 1 and 143 in group 2. The rate of BSIs decreased significantly from group 1 to group 2 (46.7% and 5.6%, respectively). The decrease in sepsis rate remained significant in a multiple regression model (regression coefficient: 1.42 +/- 0.35). The odds ratio of decreased sepsis in relation to the new policy application among the very low birth weight infants was 4.15 (95% confidence interval: 2.1-8.3).
CONCLUSION: Applying the closed medication system was associated with reduced BSI rates in our unit. This protocol was easily reproducible in our environment and showed immediate results. Serious attempts to share data can potentially optimize outcomes and standardize policies and practices among NICUs.

Entities:  

Mesh:

Year:  2005        PMID: 15930211     DOI: 10.1542/peds.2004-1785

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  23 in total

Review 1.  [Complications of peripheral regional anesthesia].

Authors:  M Neuburger; J Büttner
Journal:  Anaesthesist       Date:  2011-11       Impact factor: 1.041

2.  Time and dose-dependent impairment of neonatal respiratory motor activity after systemic inflammation.

Authors:  Nina R Morrison; Stephen M Johnson; Austin D Hocker; Rebecca S Kimyon; Jyoti J Watters; Adrianne G Huxtable
Journal:  Respir Physiol Neurobiol       Date:  2019-10-12       Impact factor: 1.931

Review 3.  Quality improvement in neonatal care - a new paradigm for developing countries.

Authors:  Deepak Chawla; Gautham K Suresh
Journal:  Indian J Pediatr       Date:  2014-04-05       Impact factor: 1.967

4.  [Arterial and central venous catheters in neonates and infants].

Authors:  M Stocker; T M Berger
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

5.  Very late onset infections in the neonatal intensive care unit.

Authors:  James L Wynn; Daniel K Benjamin; Daniel K Benjamin; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2011-09-15       Impact factor: 2.079

6.  [Successful infection control in regional anesthesia procedures: observational survey after introduction of the DGAI hygiene recommendations].

Authors:  F Reisig; M Neuburger; Y A Zausig; B M Graf; J Büttner
Journal:  Anaesthesist       Date:  2013-02-06       Impact factor: 1.041

7.  Neonatal sepsis 2004-2013: the rise and fall of coagulase-negative staphylococci.

Authors:  Matthew J Bizzarro; Veronika Shabanova; Robert S Baltimore; Louise-Marie Dembry; Richard A Ehrenkranz; Patrick G Gallagher
Journal:  J Pediatr       Date:  2015-05       Impact factor: 4.406

8.  Efficacy and Safety of Intravenous Colistin in Very Low Birth Weight Preterm Infants.

Authors:  Ozkan Ilhan; Meltem Bor; Senem Alkan Ozdemir; Sinem Akbay; Esra Arun Ozer
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

9.  Is an increased dwell time of a peripherally inserted catheter associated with an increased risk of bloodstream infection in infants?

Authors:  P Brian Smith; Daniel K Benjamin; C Michael Cotten; Eric Schultz; Rose Guo; Lisa Nowell; Mary Laura Smithwick; Courtney D Thornburg
Journal:  Infect Control Hosp Epidemiol       Date:  2008-08       Impact factor: 3.254

Review 10.  Quality improvement in pediatrics: past, present, and future.

Authors:  Stephanie P Schwartz; Kyle J Rehder
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.